GTR Home > Tests > Search results - Thanatophoric dysplasia, type 2

Apply filters

Showing test for 1 condition

reset

Compare labs

Your search term can be found in tests with a total of 1544 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C1300257[DISCUI]

C Clinical test, R Research test

Showing 1 to 18 of 18 tests for 1 condition in 10 labs

CFGFR3 gene Sequencing

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (6)

CComprehensive Epilepsy Panel

Lab: Transgenomic New Haven, Connecticut, United States
Total conditions (527)
Total targets (377)

CFGFR3 Related Disorders, Sequencing

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (6)

CepiSEEK® Comprehensive Sequence Analysis for Epilepsy and Seizure Disorders (489 genes)

Lab: Courtagen Diagnostics Laboratory Courtagen Life Sciences Woburn, Massachusetts, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (641)
Total targets (439)

CFGFR3

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (12)

CSkeletal Dysplasias NGS panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (371)
Total targets (161)

CFGFR-Related Craniosynostosis NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (25)

CCraniosynostosis NGS Panel

Lab: Transgenomic New Haven, Connecticut, United States
Total conditions (17)

CFGFR3. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CSkeletal Dysplasia

Lab: Asper Biotech Asper Biotech Ltd. Tartu, Tartumaa, Estonia
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (25)
Total targets (10)

CSkeletal Dysplasia: Sequencing Panel

Lab: Emory Genetics Laboratory Emory University Decatur, Georgia, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (365)
Total targets (163)

CLimb Malformation: Sequencing Panel

Lab: Emory Genetics Laboratory Emory University Decatur, Georgia, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (121)
Total targets (46)

CHearing Loss: Sequencing Panel

Lab: Emory Genetics Laboratory Emory University Decatur, Georgia, United States
Total conditions (154)
Total targets (87)

CDisproportionate Short Stature: Sequencing Panel

Lab: Emory Genetics Laboratory Emory University Decatur, Georgia, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (200)
Total targets (77)

CIntellectual Disability NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (752)
Total targets (392)

CEpilepsy NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (598)
Total targets (343)

CThanatophoric Dysplasia (sequence analysis of FGFR3 gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

Showing 1 to 18 of 18 tests for 1 condition in 10 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.